BioSpace News Archive

To date, there have been 830 confirmed cases and 26 deaths - all but two of the fatalities have been in Wuhan and most have been elderly

Pharmaceutical Executive®, a multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is now accepting nominations for the 2020 Emerging Pharma Leaders awards program, which recognizes and honors up-and-coming professionals who are vital to the future of the pharmaceutical and biotech industries

Koneksa Health, the leader in developing and implementing patient-focused digital biomarkers for drug development, along with Merck & Co, Inc. (NYSE: MRK) announced the publication of a peer-reviewed Phase I clinical trial evaluating the accuracy and sensitivity of mobile health (mHealth) technologies to measure heart rate and blood pressure.

AI platform was developed at the Ray and Stephanie Lane Center for Computational Biology, which became the Computational Biology Department at Carnegie Mellon University and was successfully tested by several pharma companies

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27th 2020 where CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.

In a follow-up to the landmark 2011 study that demonstrated prenatal surgery for spina bifida has measurable benefits over surgery after birth for one of the most disabling neural tube defects, researchers have published new findings.

Dr. Seth Resnick, Chair of the Psychiatry and Behavioral Health Department for AdvantageCare Physicians, has been named a Distinguished Fellow of the American Psychiatric Association for his significant contributions to the psychiatric field..

Based on encouraging therapeutic activity signals observed in preliminary post-hoc analyses and recommendations from the Independent Data Monitoring Committee, Ipsen to conduct further assessment of the complete data set and work with the regulatory authorities to determine the path forward

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it has updated the time of its fourth quarter and full year 2019 earnings call on January 30, 2020 to 7:30 a.m. Eastern Time.

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) announced today that the Company will release its fourth quarter and full year 2019 financial results on Wednesday, February 26, 2020, prior to the open of the U.S. financial markets.